AR044870A1 - Compuesto azufrado triciclico y su uso como agente terapeutico para la vejiga hiperactiva - Google Patents

Compuesto azufrado triciclico y su uso como agente terapeutico para la vejiga hiperactiva

Info

Publication number
AR044870A1
AR044870A1 ARP040102183A ARP040102183A AR044870A1 AR 044870 A1 AR044870 A1 AR 044870A1 AR P040102183 A ARP040102183 A AR P040102183A AR P040102183 A ARP040102183 A AR P040102183A AR 044870 A1 AR044870 A1 AR 044870A1
Authority
AR
Argentina
Prior art keywords
substituted
unsubstituted
defined above
same meanings
amino
Prior art date
Application number
ARP040102183A
Other languages
English (en)
Spanish (es)
Inventor
Kaoru Atsuki
Shiro Shirakura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of AR044870A1 publication Critical patent/AR044870A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ARP040102183A 2003-06-27 2004-06-23 Compuesto azufrado triciclico y su uso como agente terapeutico para la vejiga hiperactiva AR044870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003185476 2003-06-27

Publications (1)

Publication Number Publication Date
AR044870A1 true AR044870A1 (es) 2005-10-05

Family

ID=33549665

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102183A AR044870A1 (es) 2003-06-27 2004-06-23 Compuesto azufrado triciclico y su uso como agente terapeutico para la vejiga hiperactiva

Country Status (4)

Country Link
JP (1) JPWO2005000293A1 (ja)
AR (1) AR044870A1 (ja)
TW (1) TW200501938A (ja)
WO (1) WO2005000293A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200827367A (en) 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201195T1 (de) * 1995-10-16 2001-06-15 Kyowa Hakko Kogyo Kk Tricyclische verbindungen
BR9808552A (pt) * 1997-04-15 2000-05-23 Kyowa Hakko Kogyo Kk Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
EA007069B1 (ru) * 2001-03-30 2006-06-30 Киова Хакко Когио Ко., Лтд. Терапевтическое средство по поводу повышенной чувствительности мочевого пузыря
JPWO2002078710A1 (ja) * 2001-03-30 2004-07-22 協和醗酵工業株式会社 過活動膀胱治療剤
EA006448B1 (ru) * 2001-03-30 2005-12-29 Киова Хакко Когио Ко., Лтд. Лекарственное средство для лечения симптомов раздраженного мочевого пузыря, связанных с доброкачественной гиперплазией предстательной железы
WO2002078633A2 (en) * 2001-03-30 2002-10-10 Kyowa Hakko Kogyo Co., Ltd. Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia

Also Published As

Publication number Publication date
JPWO2005000293A1 (ja) 2006-08-03
WO2005000293A1 (ja) 2005-01-06
TW200501938A (en) 2005-01-16

Similar Documents

Publication Publication Date Title
AR110400A1 (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
AR119651A1 (es) Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
DOP2018000187A (es) Derivados de pirazolo[1,5-a]pirazin-4-ilo
AR088226A1 (es) Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas
AR092270A1 (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
AR068413A2 (es) Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia
CY1112886T1 (el) Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο
AR054799A1 (es) Derivados de oxindol
AR077695A1 (es) Derivados de pirimidina como inhibidores del factor ixa
CY1119220T1 (el) Μονοκυκλικο παραγωγο πυριδινης
AR072952A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
AR055592A1 (es) Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace)
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
AR088175A1 (es) 3-pirimidin-4-il-oxazolidin-2-onas utiles para tratar cancer y composiciones farmaceuticas que las contienen
AR079226A1 (es) Espiroindolinona- pirrolidinas, procesos de preparacion y uso de los mismos para el tratamiento y profilaxis del cancer
AR071763A1 (es) Pirazoles trisustituidos, composiciones farmaceuticas que los contienen, y usos de los mismos en el tratamiento de trastornos neurologicos y psiquiatricos
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
CL2019002919A1 (es) Compuestos inhibidores vmat2 y composiciones relacionadas.
AR054790A1 (es) Metodos para el tratamiento de disfuncion sexual
UY28821A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos.
AR053342A1 (es) Quinolonas y naftiridonas 7- maino alquilildenil- heterociclicas
DOP2011000283A (es) Derivados ciclopropil amina
AR068521A1 (es) Derivados heterociclicos triciclicos
UY27979A1 (es) Indoles sustituidos en posición 2,4

Legal Events

Date Code Title Description
FB Suspension of granting procedure